4893 items matching your search terms.

Metadiagnosis and clinical decisions

Simes, R. J. Cain, K. C.

Conservative surgery and radiotherapy as primary treatment for early breast cancer: results of a 10 year experience

Simes, R. J. Kearsley, J. H. Donovan, J. K.

A comparison of informed consent procedures among candidates for randomized trials of cancer treatment

Tattersall, MHN; Simes, J; Abrahams, S; Coates, A; Fox, RM; Raghavan, D; Sutherland, C; Solomon, J

Retinopathy in malaria

Davis, MW; Vaterlaws, AL; Simes, J; Torzillo, P

Activity of mouse macrophages purified by adherence to, and removal from, a plastic surface

Wood, P. R. Simes, R. J. Nelson, D. S.

Role of a non-committed accessory cell in the in vivo suppression of a syngeneic tumour by immune lymphocytes

Simes, R. J. Kearney, R. Nelson, D. S.

Canfell K, Caruana M, Gebski V, Darlington-Brown J, Heley S, Brotherton J, Gertig D, Jennett C Farnsworth A, Tan J, Wrede D, Castle P, Saville M. Cervical screening with primary HPV testing or cytology in a population of women offered HPV vaccination: Results of the Compass pilot randomized trial. PLOS Medicine 2017 (in press)

Marc S. Sabatine, MD,* Lawrence A. Leiter, MD,* Stephen D. Wiviott, MD, Robert P. Giugliano, MD, Prakash Deedwania, MD,* Gaetano M. De Ferrari, MD, Sabina A. Murphy, MPH, Julia F. Kuder, MA, Ioanna Gouni-Berthold, MD,* Basil S. Lewis, MD,* Yehuda Handelsman, MD, Armando Lira Pineda, MD, Narimon Honarpour, MD, Anthony C. Keech, MD,* Peter S. Sever, MD,* and Terje R Pedersen, MD*, on behalf of the FOURIER Investigators Cardiovascular Safety and Efficacy of the PCSK9 Inhibitor Evolocumab in Diabetes and the Risk of Development of Diabetes: A Prespecified Analysis from the Randomized Controlled FOURIER Trial. Lancet Diabetes and Endocrinology (in press – accepted 23 August 2017)

Herzog H, Shanahan M, Grimison P, Tran AD, Wong N, Lintzeris N, Simes RJ, Stockler MR, Morton RL. Systematic review of the costs and benefits of prescribed cannabis-based medicines for the management of chronic illness: lessons from multiple sclerosis. Accepted 18th August 2017, PharmacoEconomics.

Targeted LOWering of Central Blood Pressure in patients with hypertension

Sharman et al.

Personalising survival predictions in advanced colorectal cancer: the ARCAD nomogram project (accepted)

Sjoquist et al.

P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours

Wong et al.

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels with the PCSK9 Inhibitor Evolocumab in the FOURIER Trial

giugliano, R. P. et al

Cost-Effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Keech, A

AGITG NABNEC: a randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas

Khasraw, M. Lipton, L. Hofman, M. Gebski, V. Gill, A. Markman, B. Yip, S. Gibbs, E. Karapetis, C. Pavlakis, N. Wong, S.F. Ransom, D. Sjoquist, K. Michael, M. Rayani, U. Simes, J. Chantrill, L.